Large B cell diffuse lymphoma

Clinical trials for Large B cell diffuse lymphoma explained in plain language.

Never miss a new study

Get alerted when new Large B cell diffuse lymphoma trials appear

Sign up with your email to follow new studies for Large B cell diffuse lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New combo therapy aims to beat back tough lymphomas

Disease control Recruiting now

This phase 2 trial is testing a combination of two drugs—a CAR-T cell therapy (relmacabtagene autoleucel) and a PD-1 inhibitor (sintilimab)—in 30 adults with relapsed or refractory B-cell lymphoma. The goal is to see if the combo can shrink tumors and improve survival. Participan…

Matched conditions: LARGE B CELL DIFFUSE LYMPHOMA

Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated Jun 27, 2026 08:13 UTC

Large B cell diffuse lymphoma

Get alerted when new Large B cell diffuse lymphoma trials appear

New combo therapy aims to beat back tough lymphomas